3D Bioprinting

3D Systems has delivered additive manufacturing solutions to the healthcare community for more than 30 years. Having produced more than 2,000,000 serial component medical devices and 140,000 patient specific surgical cases, we are eager to bring this experience to scaling production of bioprinted clinical applications. Our technology will elevate patient care through various clinical applications ranging from acellular bioresorbable devices to functionalized solid organs for transplantation.

Together with United Therapeutics Corporation and its organ manufacturing and transplantation-focused subsidiary, Lung Biotechnology PBC, we achieved significant progress in the development of next generation bioprinting solutions for lung scaffolds that are capable of full size, vascularized, rapid, micron-level printing.

3D Systems’ capabilities as a technology innovator, spanning hardware, software, and materials science, combined with United Therapeutics’ renowned expertise in regenerative medicine has enabled advances in lung modeling, 3D printing, as well as material formulation and material handling to yield significant capabilities in bioprinters and biomaterials for the eventual production of transplantable organs.

Read more about the United Therapeutics organ manufacturing platform.

The acquisition of Volumetric Biotechnologies brings exceptional tissue engineering and biological expertise to expand the scope of human organ bioprinting efforts at 3D Systems.

We are establishing a world-class research facility in Houston, Texas to accelerate the development and commercialization of vascularized human tissues and bioprinted constructs for non-organ applications, and creating clear technological leadership in the rapidly emerging bioprinting field for laboratory applications including drug discovery.